CRGY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Crescent Energy Co (CRGY) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive indicators, such as hedge fund buying and bullish technical signals, the company's weak financial performance, declining revenue, and negative EPS make it less appealing for immediate investment. Analysts have mixed ratings, with some lowering price targets, and there are no strong proprietary trading signals to suggest a compelling entry point.
The technical indicators show a bullish trend with the MACD histogram above 0 and positively expanding, RSI in the neutral zone, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 10.781 and 11.119, while support levels are at 9.689 and 9.351. However, the stock's pre-market change of -3.49% and post-market decline of -0.28% indicate some near-term weakness.
Hedge funds are significantly increasing their positions, with a 1564.11% increase in buying over the last quarter.
The company has streamlined its asset base, improving margins and cost structure.
Analysts note potential long-term value in exploration and production stocks, with some maintaining positive ratings.
Weak financial performance in Q4 2025, including a 1.17% YoY revenue decline, a 92.66% drop in net income, and a 95.71% decline in EPS.
Analysts have lowered price targets, citing macroeconomic pressures and a transition year for the company.
No recent congress trading data or strong proprietary trading signals to support immediate action.
Crescent Energy reported a Q4 2025 revenue decline of 1.17% YoY to $865.04 million, with net income dropping 92.66% YoY to -$8.66 million. EPS fell 95.71% YoY to -$0.03, and gross margin declined 54.82% YoY to 10.97%. While the company highlighted stable production and strong cash flow, the financials indicate significant challenges.
Analysts have mixed ratings for CRGY. Wells Fargo maintains an Overweight rating but lowered the price target to $13 from $15, citing macroeconomic pressures. Jefferies resumed coverage with a Hold rating and a price target of $9, down from $10. BMO Capital initiated coverage with a Market Perform rating and a $10 price target, noting 2026 as a transition year. Evercore ISI is more optimistic with an Outperform rating and a $13 price target, citing the Vital Energy merger as a positive step.
